| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 12/08/2022 | -9.91% | UBS | $12 → $2 | Downgrades | Buy → Neutral |
| 11/08/2022 | 35.14% | B of A Securities | → $3 | Downgrades | Neutral → Underperform |
| 06/08/2022 | 80.18% | B of A Securities | $12 → $4 | Downgrades | Buy → Neutral |
| 10/19/2021 | 440.54% | HC Wainwright & Co. | $19 → $12 | Maintains | Buy |
| 10/08/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 10/06/2021 | 755.86% | HC Wainwright & Co. | $32 → $19 | Maintains | Buy |
| 10/04/2021 | — | Maxim Group | Downgrades | Buy → Hold | |
| 09/27/2021 | 575.68% | JP Morgan | → $15 | Initiates Coverage On | → Neutral |
| 06/18/2021 | 4404.5% | WBB Securities | $75 → $100 | Maintains | Strong Buy |
| 04/26/2021 | 1341.44% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 02/01/2021 | 1026.13% | UBS | → $25 | Initiates Coverage On | → Buy |
| 01/20/2021 | 1431.53% | HC Wainwright & Co. | $31 → $34 | Maintains | Buy |
| 01/04/2021 | 1296.4% | HC Wainwright & Co. | $32 → $31 | Maintains | Buy |
| 10/20/2020 | 845.95% | B of A Securities | → $21 | Initiates Coverage On | → Buy |
| 09/01/2020 | 440.54% | Wedbush | $17 → $12 | Maintains | Neutral |
| 08/21/2020 | 1341.44% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 12/02/2019 | 1431.53% | HC Wainwright & Co. | $35 → $34 | Reiterates | → Buy |
| 05/06/2019 | 1071.17% | Cantor Fitzgerald | → $26 | Initiates Coverage On | → Overweight |
| 08/10/2018 | 1341.44% | Maxim Group | $25 → $32 | Maintains | Buy |
| 05/17/2018 | 800.9% | Wedbush | $19 → $20 | Maintains | Neutral |
| 03/23/2018 | 1026.13% | Maxim Group | $24 → $25 | Maintains | Buy |
| 03/23/2018 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 03/22/2018 | 1026.13% | Maxim Group | $24 → $25 | Maintains | Buy |
What is the target price for Omeros (OMER)?
The latest price target for Omeros (NASDAQ: OMER) was reported by UBS on December 8, 2022. The analyst firm set a price target for $2.00 expecting OMER to fall to within 12 months (a possible -9.91% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Omeros (OMER)?
The latest analyst rating for Omeros (NASDAQ: OMER) was provided by UBS, and Omeros downgraded their neutral rating.
When is the next analyst rating going to be posted or updated for Omeros (OMER)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omeros, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omeros was filed on December 8, 2022 so you should expect the next rating to be made available sometime around December 8, 2023.
Is the Analyst Rating Omeros (OMER) correct?
While ratings are subjective and will change, the latest Omeros (OMER) rating was a downgraded with a price target of $12.00 to $2.00. The current price Omeros (OMER) is trading at is $2.22, which is out of the analyst's predicted range.